Assessment of airway inflammation: An overview

European Respiratory Journal, Supplement

Volumn 11, Issue 26, 1998, Pages

  Fabbri, L M ^a   Durham, S ^a   Holgate, S T ^a   O'Byrne, P M ^a   Postma, D S ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BRONCHOSCOPY; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; HUMAN; INFLAMMATION; LUNG LAVAGE; NEUTROPHILIA; PRIORITY JOURNAL; SHORT SURVEY; SPUTUM ANALYSIS; BRONCHUS HYPERREACTIVITY; CYTOLOGY; NEEDLE BIOPSY; PATHOPHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM;

ASTHMA; BIOPSY, NEEDLE; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; HUMANS; INFLAMMATION; LUNG DISEASES, OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 0032018820     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Sheffer AL, ed. Global initiative for asthma. NHLBI/WHO Workshop report. National Institutes of Health, National Heart, Lung and Blood Institute. Publication No. 95-3659. January 1995.
2. The British Thoracic Society, the National Asthma Campaign, the Royal College of Physicians of London in association with the General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52 (Suppl. 1): S1-S21.
3. Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (Suppl.): S77-S120.
4. Siafakas NM, Vermeire P, Pride NB, et al. on behalf of the Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
5. Laitinen LA, Heino M, Laitinen A, Kava T, Haatela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131: 599-606.
6. Saetta M. Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 7: 29-33.
7. Wever AMJ, Wever-Hess J, Dahl R. Use of assessment of inflammation in management of drug therapy in asthma. Clin Immunother 1995; 4: 462-470.
8. Kumlin M, Stensvad F, Larsson L, Dahlén B, Dahlén S-E. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin Exp Allergy 1995; 25: 467-179.
9. Kirby GJ, Hargreave FE, Gleich GJ, O'Byrne PM. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136: 379-383.
10. Jeffery PK, Godfrey RW, Adelroth E, Nelson FC, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
11. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62-69.
12. Chetta A, Foresi A, Del Donno M, et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996; 153: 910-917.
13. Josephs LK, Gregg I, Mullee MA, Holgate ST. Non specific bronchial reactivity and its relationship to the clinical expression of asthma: a longitudinal study. Am Rev Respir Dis 1989; 140: 350-357.
14. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995; 16: 128-130.
15. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996; 9: 2671-2680.
16. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.